A protein kinase associated with apoptosis and tumor suppression: structure, activity, and discovery of peptide

A V Velentza1, A M Schumacher, C Weiss

  • 1Drug Discovery Program and Department of Molecular Pharmacology and Biological Chemistry, Northwestern University, Chicago, Illinois 60611, USA.

Insights

Researchers identified peptide substrates for Death-associated protein kinase (DAPK), a key enzyme in apoptosis and tumor suppression. This discovery advances understanding of DAPK

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Enzymology

Background:

  • Death-associated protein kinase (DAPK) is linked to apoptosis and tumor suppression but lacks characterized enzyme activity due to unknown substrates.
  • Understanding DAPK's enzymatic function is crucial for elucidating its role in disease mechanisms.

Purpose of the Study:

  • To identify specific peptide substrates for DAPK.
  • To determine DAPK's substrate specificity and preferences for phosphorylation sites.
  • To develop an enzyme assay for DAPK activity.

Main Methods:

  • Determined the structure of the DAPK catalytic domain.
  • Utilized homology modeling for docked peptide substrates.
  • Synthesized positional scanning substrate libraries to discover substrates.
  • Performed site-directed mutagenesis on the DAPK catalytic domain.
  • Developed and applied an enzyme assay for DAPK activity.

Main Results:

  • Discovered peptide substrates with K(m) values around 10 micromolar for DAPK.
  • Elucidated DAPK's preferences for specific phosphorylation site sequences.
  • Established a structure-activity relationship through mutagenesis.
  • Developed a functional enzyme assay for DAPK, enabling activity measurement in adult brain tissue and monitoring protein purification.

Conclusions:

  • The study provides the first characterization of DAPK as an enzyme by identifying its peptide substrates.
  • Findings offer insights into DAPK substrate preferences and regulation, laying groundwork for proteomic studies and inhibitor development.
  • The experimental approach is applicable to other kinases lacking known substrates.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...